ISHARES TR - U.S. PHARMA ETF (IHE)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / U.S. PHARMA ETF
Shares, excl. options Q1 2024
5.22 M
Holdings value Q1 2024
$354 M
Value change Q1 2024
+$213 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
135
Number of buys Q1 2024
126
Number of sells Q1 2024
-18
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
464288836
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 5.22 M $354 M +$213 M $67.90 135
2023 Q4 1.89 M $351 M +$241 M $185.40 131
2023 Q3 649 K $115 M -$5.41 M $176.98 122
2023 Q2 674 K $121 M -$9.71 M $179.11 114
2023 Q1 729 K $128 M -$9.78 M $175.28 122
2022 Q4 742 K $138 M +$8.78 M $186.13 122
2022 Q3 686 K $116 M -$7.56 M $169.54 104
2022 Q2 742 K $142 M +$34 M $191.65 115
2022 Q1 560 K $109 M +$8.36 M $194.25 112
2021 Q4 519 K $104 M -$3.38 M $199.66 105
2021 Q3 535 K $98.1 M +$981 K $183.13 106
2021 Q2 528 K $98.1 M +$6.46 M $185.74 97
2021 Q1 492 K $87.4 M -$2.26 M $177.66 98
2020 Q4 504 K $90.4 M +$3.77 M $179.44 94
2020 Q3 484 K $79.1 M -$9.04 M $163.53 90
2020 Q2 542 K $83.4 M +$14.1 M $153.87 87
2020 Q1 442 K $59.5 M -$20.5 M $134.58 89
2019 Q4 599 K $95.8 M -$71.2 M $160.11 90
2019 Q3 1.05 M $147 M +$43.8 M $139.85 80
2019 Q2 732 K $110 M +$8.53 M $150.79 82
2019 Q1 675 K $104 M -$234 K $153.97 89
2018 Q4 684 K $96.3 M -$28.9 M $140.76 92
2018 Q3 878 K $147 M -$909 K $167.84 95
2018 Q2 872 K $132 M -$9.9 M $151.35 88
2018 Q1 944 K $139 M -$138 M $147.54 99
2017 Q4 1.85 M $285 M -$31.4 M $154.38 105
2017 Q3 2.02 M $317 M -$32.6 M $156.36 99
2017 Q2 2.24 M $347 M -$14.5 M $155.13 91
2017 Q1 2.3 M $348 M +$60.5 M $150.94 95
2016 Q4 1.95 M $276 M +$115 M $141.42 92
2016 Q3 1.08 M $161 M -$44.3 M $149.44 84
2016 Q2 1.36 M $197 M -$20.5 M $144.40 88
2016 Q1 1.49 M $205 M -$99.3 M $136.98 89
2015 Q4 1.92 M $309 M -$760 K $161.69 102
2015 Q3 2.16 M $321 M -$24.1 M $148.02 102
2015 Q2 2.31 M $404 M -$49.6 M $174.82 118
2015 Q1 2.54 M $437 M +$86.7 M $172.42 107
2014 Q4 2.05 M $311 M +$27.1 M $151.40 101
2014 Q3 1.84 M $259 M -$10.4 M $140.35 85
2014 Q2 1.92 M $259 M -$2.84 M $135.11 86
2014 Q1 1.95 M $247 M +$26.5 M $126.69 85